Keywords
Last Name
Institution

RONALD KERMAN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Surgery
DivisionSurgery-Transplant Division
AddressNeurosensory Center
6500 Fannin, Suite NA 425
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Overview 
    Collapse overview
    Dr. Ronald H. Kerman directs a clinical transplant immunology laboratory. Research interests are focused on determining the strength of transplant patient cellular and antibody immune responsiveness as it relates to immunologic rejection and graft loss. Studies are underway to determine the identity of HLA and non-HLA clinically relevant antibodies and their role in graft rejection. In addition, studies are being conducted to determine the immune response of patients receiving allogeneic stem cell infusions.

    Dr. Kerman's bibliography currently includes 360 abstracts and presentations and nearly 200 published works, including 22 book chapters. Dr. Kerman held positions at Jefferson Medical College in Philadelphia and the Stritch School of Medicine in Loyola University in Chicago before coming to Baylor College of Medicine in 1977 when the transplantation center opened. Immunology has flourished since Dr. Kerman first became interested in the specialty in 1964. The comprehensive range of services and quality of performance offered by the transplantation service place it among the world's top transplant immunology facilities.

    Collapse keywords
    • Immune response - allogeneic stem cells
    • Cellular and antibody immune responsiveness
    • HLA antibodies


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kerman R, Saltarrelli J, McKissick E, Eaton J, Woolley N, Hoover A, Acorda N, Erice P, Hollingsworth C, Chappelle J, O'Mahony C, Van Buren C. Can we use dilution-titration studies to identify clinically relevant HLA antibody specificities? Clin Transpl. 2013; 357-60. PMID: 25095529.
      View in: PubMed
    2. Knight RJ, Podder H, Kerman RH, Lawless A, Katz SM, Van Buren CT, Gaber AO, Kahan BD. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation. Transplantation. 2010 Mar 27; 89(6):727-32. PMID: 20195219.
      View in: PubMed
    3. Kobashigawa J, Mehra M, West L, Kerman R, George J, Rose M, Zeevi A, Reinsmoen N, Patel J, Reed EF. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant. 2009 Mar; 28(3):213-25. PMID: 19285611; PMCID: PMC3878294.
    4. Kaposztas Z, Podder H, Mauiyyedi S, Illoh O, Kerman R, Reyes M, Pollard V, Kahan BD. Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant. 2009 Jan-Feb; 23(1):63-73. PMID: 19200217.
      View in: PubMed
    5. Knight RJ, Kerman RH, McKissick E, Lawless A, Podder H, Katz S, Van Buren CT, Kahan BD. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Clin Transplant. 2008 Sep-Oct; 22(5):645-50. PMID: 18657156.
      View in: PubMed
    6. Zhao W, Guerrero E, Kerman RH, Cano P, Fernández-Viña MA. DRB1*1613N: a novel DRB1 allele with a premature termination codon. Tissue Antigens. 2008 Feb; 71(2):180-2. PMID: 18086264.
      View in: PubMed
    7. Knight RJ, Villa M, Laskey R, Benavides C, Schoenberg L, Welsh M, Kerman RH, Podder H, Van Buren CT, Katz SM, Kahan BD. Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients. Clin Transplant. 2007 Jul-Aug; 21(4):460-5. PMID: 17645704.
      View in: PubMed
    8. Kerman RH. Understanding the sensitized patient. Heart Fail Clin. 2007 Jan; 3(1):1-9. PMID: 17545004.
      View in: PubMed
    9. Kerman R, Lappin J, Kahan B, Katz S, McKissick E, Hosek K, Acorda N, Wooley N, Hoover A, Miller K, Rodriguez L, Moore B, Melcher P, Biedermann B, Van Buren C. The crossmatch may still be the most clinically relevant histocompatibility test performed. Clin Transpl. 2007; 227-9. PMID: 18642454.
      View in: PubMed
    10. Csapo Z, Knight RJ, Podder H, Kerman RH, Schoenberg L, Katz SM, Van Buren CT, Kahan BD. Long-term outcomes of single paediatric vs. ideal adult renal allograft transplants in adult recipients. Clin Transplant. 2006 Jul-Aug; 20(4):423-6. PMID: 16842516.
      View in: PubMed
    11. Knight RJ, Kerman RH, Zela S, Podbielski J, Podder H, Van Buren CT, Katz S, Kahan BD. Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine. Transplantation. 2006 Apr 27; 81(8):1101-5. PMID: 16641593.
      View in: PubMed
    12. Podder H, Kerman RH, Illoh OC, Kahan BD. Sickle cell disease: a formidable enemy of the transplanter. Clin Transpl. 2006; 570-1. PMID: 18365438.
      View in: PubMed
    13. Zhang Y, Kirken RA, Furian L, Janczewska S, Qu X, Hancock WW, Wang M, Tejpal N, Kerman R, Kahan BD, Stepkowski SM. Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. J Immunol. 2006 Jan 1; 176(1):128-37. PMID: 16365403.
      View in: PubMed
    14. Knight RJ, Kerman RH, McKissick E, Lawless A, Podder H, Katz S, Van Buren CT, Kahan BD. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Transplant Proc. 2005 Oct; 37(8):3538-41. PMID: 16298653.
      View in: PubMed
    15. Csapo Z, Knight RJ, Podder H, Kerman RH, Schoenberg L, Katz SM, Van Buren CT, Kahan BD. Transplantation of single pediatric kidneys into adult recipients. Transplant Proc. 2005 Mar; 37(2):697-8. PMID: 15848505.
      View in: PubMed
    16. Knight RJ, Kerman RH, Podder H, Katz SM, Van Buren CT, Kahan BD. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine. Transplant Proc. 2005 Mar; 37(2):1280-2. PMID: 15848695.
      View in: PubMed
    17. Stepkowski SM, Knight R, Podder H, Kerman R. Our picks of big and not so big issues. Ann Transplant. 2005; 10(3):37-40. PMID: 16617665.
      View in: PubMed
    18. Knight RJ, Kerman RH, Schoenberg L, Podder H, Van Buren CT, Katz S, Kahan BD. The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function. Transplantation. 2004 Sep 27; 78(6):904-10. PMID: 15385812.
      View in: PubMed
    19. Knight RJ, Zela S, Schoenberg L, Podder H, Kerman RH, Katz S, Van Buren CT, Kahan BD. The effect of pancreas transplantation on peripheral vascular disease complications. Transplant Proc. 2004 May; 36(4):1069-71. PMID: 15194371.
      View in: PubMed
    20. Bray RA, Nickerson PW, Kerman RH, Gebel HM. Evolution of HLA antibody detection: technology emulating biology. Immunol Res. 2004; 29(1-3):41-54. PMID: 15181269.
      View in: PubMed
    21. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant. 2003 Jun; 3(6):708-14. PMID: 12780562.
      View in: PubMed
    22. Kahan BD, Knight R, Schoenberg L, Pobielski J, Kerman RH, Mahalati K, Yakupoglu Y, Aki FT, Katz S, Van Buren CT. Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience. Transplant Proc. 2003 May; 35(3 Suppl):25S-34S. PMID: 12742465.
      View in: PubMed
    23. Knight RJ, Kerman RH, Zela S, Podder H, Van Buren CT, Katz S, Kahan BD. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Transplantation. 2003 Apr 27; 75(8):1301-6. PMID: 12717220.
      View in: PubMed
    24. Kerman RH, Katz SM, Van Buren CT, Ruth J, McKissick E, Rasmussen S, Kahan BD. Posttransplant immune monitoring of anti-HLA antibody. Transplant Proc. 2001 Feb-Mar; 33(1-2):402. PMID: 11266882.
      View in: PubMed
    25. Kerman RH, Katz SM, Van Buren CT, Garcia C, Kahan BD. Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibody. Transplant Proc. 2001 Feb-Mar; 33(1-2):401. PMID: 11266881.
      View in: PubMed
    26. Gebel HM, Bray RA, Ruth JA, Zibari GB, McDonald JC, Kahan BD, Kerman RH. Flow PRA to detect clinically relevant HLA antibodies. Transplant Proc. 2001 Feb-Mar; 33(1-2):477. PMID: 11266916.
      View in: PubMed
    27. Kerman RH, Radovancevic B, Przybylowski P, Frazier OH, Thomas C, Kahan BD. LVAD treated heart recipients do not have deleterious HLA antibody. J Heart Lung Transplant. 2001 Feb; 20(2):211. PMID: 11250384.
      View in: PubMed
    28. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001; 1 Suppl 2:3-95. PMID: 12108435.
      View in: PubMed
    29. Gruber SA, Katz S, Kaplan B, Clark JH, Chen PC, El-Sabrout R, Kerman RH. Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. Transplantation. 2000 Jul 27; 70(2):388-91. PMID: 10933170.
      View in: PubMed
    30. Kerman RH. Post-transplant immune serological markers may be predictive of chronic rejection. Ann Transplant. 2000; 5(2):24-8. PMID: 11217203.
      View in: PubMed
    31. Kerman RH, Susskind B, Buyse I, Pryzbylowski P, Ruth J, Warnell S, Gruber SA, Katz S, Van Buren CT, Kahan BD. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation. 1999 Dec 27; 68(12):1855-8. PMID: 10628764.
      View in: PubMed
    32. Clark J, Kerman R, Susskind B, Katz S, Van Buren C, Kahan B. Correlation of pretransplant allosensitization with severity of rejection biopsy. Transplant Proc. 1999 Feb-Mar; 31(1-2):751-2. PMID: 10083321.
      View in: PubMed
    33. Przybylowski P, Balogna M, Radovancevic B, Frazier OH, Susskind B, Van Buren C, Katz S, Kahan BD, Kerman R. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients. Transplantation. 1999 Jan 27; 67(2):258-62. PMID: 10075590.
      View in: PubMed
    34. Kerman RH, Susskind B, Ruth J, Katz S, Van Buren CT, Kahan BD. Can an immunologically, nonreactive potential allograft recipient undergo transplantation without a donor-specific crossmatch? Transplantation. 1998 Dec 27; 66(12):1833-4. PMID: 9884284.
      View in: PubMed
    35. Susskind B, Kerman RH, Nelson R, Gregory J, La T, Bayat A, Dang M, Van Buren C, Katz S, Kahan BD. Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies. Transplantation. 1998 Dec 27; 66(12):1823-6. PMID: 9884282.
      View in: PubMed
    36. Kerman RH, Susskind B, Kerman D, Lam M, Gerolami K, Williams J, Kalish R, Campbell M, Katz S, Van Buren CT, Frazier H, Radovancevic B, Fife S, Kahan B. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. J Heart Lung Transplant. 1998 Aug; 17(8):789-94. PMID: 9730428.
      View in: PubMed
    37. Lindsey JW, Kerman RH, Wolinsky JS. T cell-T cell activation in multiple sclerosis. Mult Scler. 1997 Aug; 3(4):238-42. PMID: 9372506.
      View in: PubMed
    38. Kerman RH, Orosz CG, Lorber MI. Clinical relevance of anti-HLA antibodies pre and post transplant. Am J Med Sci. 1997 May; 313(5):275-8. PMID: 9145036.
      View in: PubMed
    39. Kerman RH, Susskind B, Katz SM, Van Buren CT, Kahan BD. Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders. Transplant Proc. 1997 Feb-Mar; 29(1-2):1410-1. PMID: 9123358.
      View in: PubMed
    40. Kerman RH, Susskind B, Slaton J, Lewis RM, Heydari A, Ruth J, Williams J, Van Buren CT, Katz SM, Kahan BD. Improved graft survival in 100 retransplant recipients following AHG-negative crossmatching. Transplant Proc. 1997 Feb-Mar; 29(1-2):1451-3. PMID: 9123377.
      View in: PubMed
    41. Kerman RH, Katz SM, Schoenberg L, Baraket O, Van Buren CT, Kahan BD. Ten-year follow-up of mixed lymphocyte reaction-hyporesponsive living related cyclosporine monotherapy-treated renal allograft recipients. Transplant Proc. 1997 Feb-Mar; 29(1-2):198-9. PMID: 9122961.
      View in: PubMed
    42. Brod SA, Kerman RH, Nelson LD, Marshall GD, Henninger EM, Khan M, Jin R, Wolinsky JS. Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis. Mult Scler. 1997 Feb; 3(1):1-7. PMID: 9160341.
      View in: PubMed
    43. Kerman RH, Susskind B, Kerman DH, Lam M, Gerolami K, Williams J, Kalish R, Campbell M, Katz SM, Van Buren CT, Kahan BD. Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):1515-6. PMID: 9123406.
      View in: PubMed
    44. Kerman RH, Susskind B, Buelow R, Regan J, Pouletty P, Williams J, Gerolami K, Kerman DH, Katz SM, Van Buren CT, Kahan BD. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation. 1996 Jul 27; 62(2):201-5. PMID: 8755816.
      View in: PubMed
    45. Susskind BM, Kerman RH, Browne BJ, Hartwell BA, Davis BG, Katz SM, Van Buren CT, Kahan BD. The impact of elevated serum IgA and race on primary recipient renal allograft survival. Transplantation. 1996 Jan 27; 61(2):205-11. PMID: 8600624.
      View in: PubMed
    46. Brod SA, Khan M, Kerman RH, Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J Neuroimmunol. 1995 Apr; 58(1):61-9. PMID: 7537281.
      View in: PubMed
    47. Brod SA, Khan M, Bright J, Sriram S, Marshall GD, Henninger EM, Kerman RH, Wolinsky JS. Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis. Ann Neurol. 1995 Apr; 37(4):546-9. PMID: 7717692.
      View in: PubMed
    48. Kerman RH, Sullivan EK, Tejani A. Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival. Transplant Proc. 1995 Feb; 27(1):656-7. PMID: 7879133.
      View in: PubMed
    49. Kimball P, Radovancevic B, Isom T, Frazier B, Kerman R. Cytokine panel predicts early rejection and therapeutic response after cardiac transplantation. Transplant Proc. 1995 Feb; 27(1):1286-7. PMID: 7878884.
      View in: PubMed
    50. Scheinin SA, Radovancevi? B, Kimball P, Duncan JM, Van Buren CT, Frazier OH, Kerman R. Effect of IgM-positive crossmatches on survival in heart transplant recipients. Tex Heart Inst J. 1995; 22(1):67-71. PMID: 7787472; PMCID: PMC325212.
    51. Lewis R, Podbielski J, Munsell M, Katz S, Van Buren C, Kerman R, Kahan BD. Stability of renal allograft glomerular filtration rate in the cyclosporine era: 2-year follow-up. Transplant Proc. 1994 Oct; 26(5):2619-21. PMID: 7940815.
      View in: PubMed
    52. Kerman RH. Relevance of histocompatibility testing in clinical transplantation. Surg Clin North Am. 1994 Oct; 74(5):1015-28. PMID: 7940059.
      View in: PubMed
    53. Kerman RH, Kimball PM, Williams J, Heydari A, Cavazos D, Ruth J, Katz S, Ozaki C, Clark J, Kahan BD, et al. Immunoregulatory mechanisms identified in liver transplant recipients. Transplant Proc. 1994 Oct; 26(5):2857-8. PMID: 7940900.
      View in: PubMed
    54. Knight RJ, Kurrle R, McClain J, Racenberg J, Baghdahsarian V, Kerman R, Lewis R, van Buren CT, Kahan BD. Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor. Transplantation. 1994 Jun 15; 57(11):1581-8. PMID: 8009591.
      View in: PubMed
    55. Jones CM, Poddar S, Goldstein R, Krupen KI, Kerman RH, Prince C, Shadduck RK. Human MCF activates monocytes to produce IL-1 but not TNF or CSF-1. Immunobiology. 1994 Jun; 190(4-5):303-16. PMID: 7982717.
      View in: PubMed
    56. Lewis RM, Verani RR, Vo C, Katz SM, Van Buren CT, Radovancevic B, Kerman RH, Frazier OH, Kahan BD. Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation. J Heart Lung Transplant. 1994 May-Jun; 13(3):376-80. PMID: 8061012.
      View in: PubMed
    57. Kerman RH, Kimball P, Scheinen S, Radovancevic B, Van Buren CT, Kahan BD, Frazier OH. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients. Transplantation. 1994 Mar 27; 57(6):884-8. PMID: 8154036.
      View in: PubMed
    58. Katz SM, Kimball PM, Ozaki C, Monsour H, Clark J, Cavazos D, Kahan BD, Wood RP, Kerman RH. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation. 1994 Feb 27; 57(4):616-20. PMID: 8116049.
      View in: PubMed
    59. Kerman RH, Kimball PM, Lindholm A, Van Buren CT, Katz SM, Lewis RM, McClain J, Podbielski J, Williams J, Kahan BD. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival. Transplantation. 1993 Nov; 56(5):1242-7. PMID: 8249130.
      View in: PubMed
    60. Lewis RM, Podbielski J, Munsell M, Katz S, Van Buren C, Kerman R, Kahan B. Optimization and long-term evaluation of renal function in sandimmune-treated renal allograft recipients. Transplant Proc. 1993 Aug; 25(4 Suppl 3):10-2. PMID: 8351704.
      View in: PubMed
    61. Kerman RH, Kimball PM, Lindholm A, Van Buren CT, Katz SM, Lewis RM, Podbielski J, Williams J, Kahan BD. Immune risk factors: impact on the incidence and diagnosis of rejection. Transplant Proc. 1993 Aug; 25(4 Suppl 3):23-5. PMID: 8351709.
      View in: PubMed
    62. Lewis R, Podbielski J, Sprayberry S, Munsell M, Katz S, Rubin M, Kimball P, Van Buren CT, Kerman R, Kahan B. Stability of renal allograft glomerular filtration rate associated with long-term use of cyclosporine A. Transplantation. 1993 May; 55(5):1014-7. PMID: 8497874.
      View in: PubMed
    63. Kimball PM, Kerman RK, Van Buren CT, Lewis RM, Katz S, Kahan BD. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication. Transplantation. 1993 May; 55(5):1128-32. PMID: 8497893.
      View in: PubMed
    64. Kimball P, Kerman RH, Williams J, Kahan BD. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay. Transplant Proc. 1993 Feb; 25(1 Pt 1):518-9. PMID: 8438397.
      View in: PubMed
    65. McCarthy M, Lovett A, Kerman RH, Overstreet A, Wolinsky JS. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides. J Virol. 1993 Feb; 67(2):673-81. PMID: 7678302; PMCID: PMC237418.
    66. Kerman R. The role of HLA typing in clinical kidney transplants: 30 years later To match or not to match? That is the question! Clin Transpl. 1993; 431-3. PMID: 7918176.
      View in: PubMed
    67. Meehan MA, Kerman RH, Lemire JM. 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol. 1992 Apr; 140(2):400-9. PMID: 1531943.
      View in: PubMed
    68. Lewis R, Katz S, Van Buren C, Kerman R, Kahan B. Mechanisms and amelioration of acute renal allograft failure in the cyclosporine era. Ren Fail. 1992; 14(3):267-84. PMID: 1387238.
      View in: PubMed
    69. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Cavazos D, Heydari A, Kahan BD. Influence of race on crossmatch outcome and recipient eligibility for transplantation. Transplantation. 1992 Jan; 53(1):64-7. PMID: 1733088.
      View in: PubMed
    70. Kerman RH. The role of crossmatching in organ transplantation. Arch Pathol Lab Med. 1991 Mar; 115(3):255-9. PMID: 2001166.
      View in: PubMed
    71. Katz SM, Kerman RH, Golden D, Grevel J, Camel S, Lewis RM, Van Buren CT, Kahan BD. Preemptive transplantation--an analysis of benefits and hazards in 85 cases. Transplantation. 1991 Feb; 51(2):351-5. PMID: 1825243.
      View in: PubMed
    72. Kimball PM, Kerman RH, Kahan BD. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase. Transplant Proc. 1991 Feb; 23(1 Pt 1):323-4. PMID: 1990544.
      View in: PubMed
    73. Kimball PM, Kerman RH. Erythropoietin: a potential immunomodulator? Transplant Proc. 1991 Feb; 23(1 Pt 1):336. PMID: 1990548.
      View in: PubMed
    74. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Stronger immune responsiveness of blacks vs whites may account for renal allograft survival differences. Transplant Proc. 1991 Feb; 23(1 Pt 1):380-2. PMID: 1990558.
      View in: PubMed
    75. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, DeVera V, Baghdahsarian V, Heydari A, Kahan BD. Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients. Transplant Proc. 1991 Feb; 23(1 Pt 1):400-2. PMID: 1990565.
      View in: PubMed
    76. Kimball PM, Kerman RH, Kahan BD. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression. Transplant Proc. 1991 Feb; 23(1 Pt 2):1027-8. PMID: 1989147.
      View in: PubMed
    77. Radovancevic B, Birovljev S, Vega JD, Lonquist JL, Sweeney MS, Vasiljevic JD, Van Buren CT, Kerman RH, Frazier OH. Inverse relationship between human leukocyte antigen match and development of coronary artery disease. Transplant Proc. 1991 Feb; 23(1 Pt 2):1144-5. PMID: 1989173.
      View in: PubMed
    78. Knight RJ, Kerman RH, Welsh M, Golden D, Schoenberg L, Van Buren CT, Lewis RM, Kahan BD. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy. Transplantation. 1991 Feb; 51(2):355-9. PMID: 1994527.
      View in: PubMed
    79. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, DeVera V, Baghdahsarian V, Heydari A, Kahan BD. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival. Transplantation. 1991 Feb; 51(2):316-20. PMID: 1994522.
      View in: PubMed
    80. Kimball PM, Kerman RH, Kahan BD. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation. 1991 Feb; 51(2):486-90. PMID: 1825247.
      View in: PubMed
    81. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation. 1991 Feb; 51(2):338-42. PMID: 1825242.
      View in: PubMed
    82. Kimball PM, Kerman RH, Kahan BD. Failure of prolyl-peptidyl isomerase to mediate cyclosporine suppression of intracellular activation signal generation. Transplantation. 1991 Feb; 51(2):509-13. PMID: 1994547.
      View in: PubMed
    83. Lewis RM, Van Buren CT, Radovancevic B, Frazier OH, Janney RP, Powers PL, Golden DL, Giannakis JG, Macris MP, Kerman RH, et al. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients. J Heart Lung Transplant. 1991 Jan-Feb; 10(1 Pt 1):63-70. PMID: 2007172.
      View in: PubMed
    84. Nath A, Kerman RH, Novak IS, Wolinsky JS. Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report. Neurology. 1990 Apr; 40(4):581-3. PMID: 2138717.
      View in: PubMed
    85. Kimball PM, Kerman RH, Kahan BD. Sensitivity of intracellular signals responsible for cell cycle progression to cyclosporine. Transplantation. 1990 Jan; 49(1):186-91. PMID: 1689083.
      View in: PubMed
    86. Kerman RH, Van Buren CT, Lewis RM, DeVera V, Baghdahsarian V, Gerolami K, Kahan BD. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation. 1990 Jan; 49(1):52-6. PMID: 2301027.
      View in: PubMed
    87. Vathsala A, Verani R, Schoenberg L, Lewis RM, Van Buren CT, Kerman RH, Kahan BD. Proteinuria in cyclosporine-treated renal transplant recipients. Transplantation. 1990 Jan; 49(1):35-41. PMID: 2301024.
      View in: PubMed
    88. Dunn J, Vathsala A, Golden D, Kerman R, Lawen J, Van Buren CT, Lewis R, Kahan BD. Impact of race on the outcome of renal transplantation under cyclosporine-prednisone. Transplant Proc. 1989 Dec; 21(6):3946-8. PMID: 2609413.
      View in: PubMed
    89. Lewis R, Kerr N, Van Buren C, Lowry P, Sandler C, Frazier OH, Powers P, Herson J, Corriere J, Kerman R, et al. Comparative evaluation of urographic contrast media, inulin, and 99mTc-DTPA clearance methods for determination of glomerular filtration rate in clinical transplantation. Transplantation. 1989 Nov; 48(5):790-6. PMID: 2815251.
      View in: PubMed
    90. Nath A, Wolinsky JS, Kerman RH. Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosis. J Neuroimmunol. 1989 Apr; 22(2):143-8. PMID: 2925842.
      View in: PubMed
    91. Lewis RM, Van Buren CT, Macris M, Frazier OH, Janney RP, McAndrew J, Kerman RH, Kahan BD. Evolution of renal function in cardiac vs. renal allograft recipients receiving long-term cyclosporine A (CsA) immunosuppressive therapy. Transplant Proc. 1989 Feb; 21(1 Pt 2):1523-4. PMID: 2652490.
      View in: PubMed
    92. Lewis RM, Janney RP, Golden DL, Kerr NB, Van Buren CT, Kerman RH, Kahan BD. Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy--five year follow-up. Transplantation. 1989 Feb; 47(2):266-72. PMID: 2645711.
      View in: PubMed
    93. Smith AY, Citterio F, Welsh M, Kerman RH, Kahan BD. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity. Transplant Proc. 1989 Feb; 21(1 Pt 2):1462-4. PMID: 2652467.
      View in: PubMed
    94. Kahan BD, Kerman RH, Van Buren CT, Flechner SM, Golden DL, Lewis RM. Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor. Transplant Proc. 1989 Feb; 21(1 Pt 2):1579-80. PMID: 2523588.
      View in: PubMed
    95. Kerman RH. Transfusions in nonrenal transplantation. Transplant Proc. 1988 Dec; 20(6):1071-3. PMID: 3059588.
      View in: PubMed
    96. Kerman RH, Wolinsky JS, Nath A, Sears ES. Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients. J Neuroimmunol. 1988 Jul; 18(4):325-31. PMID: 2968363.
      View in: PubMed
    97. Smith AY, Van Buren CT, Lewis RM, Kerman RH, Welsh M, Kahan BD. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine. Transplant Proc. 1988 Jun; 20(3 Suppl 3):180-93. PMID: 3291239.
      View in: PubMed
    98. Smith AY, Kerman RH, Van Buren CT, Lewis RM, Kahan BD. Pediatric cadaveric kidneys in recipients treated with cyclosporine. Transplant Proc. 1988 Jun; 20(3 Suppl 3):215-21. PMID: 3291246.
      View in: PubMed
    99. Lewis RM, Janney RP, Van Buren CT, Kerman RH, Herson J, Kerr NA, Golden DA, Kahan BD. A retrospective analysis of long-term renal allograft function associated with cyclosporine-prednisone immunosuppressive therapy. Transplant Proc. 1988 Jun; 20(3 Suppl 3):534-9. PMID: 3291291.
      View in: PubMed
    100. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988 Jun; 20(3 Suppl 3):63-9. PMID: 3291299.
      View in: PubMed
    101. Kerman RH, Van Buren CT, Lewis RM, Kahan BD. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Transplant Proc. 1988 Jun; 20(3 Suppl 3):264-9. PMID: 3291254.
      View in: PubMed
    102. Kerman RH. Effects of cyclosporine immunosuppression in humans. Transplant Proc. 1988 Apr; 20(2 Suppl 2):143-52. PMID: 3284064.
      View in: PubMed
    103. Smith AY, Van Buren CT, Lewis RM, Kerman RH, Kahan BD. Short-term and long-term function of cadaveric kidneys from pediatric donors in recipients treated with cyclosporine. Transplantation. 1988 Feb; 45(2):360-7. PMID: 3278429.
      View in: PubMed
    104. Lewis RM, Johnson PC, Golden D, Van Buren CT, Kerman RH, Kahan BD. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients. Transplantation. 1988 Feb; 45(2):353-9. PMID: 2830686.
      View in: PubMed
    105. Kerman RH, van Buren CT, Lewis RM, Frazier OH, Cooley D, Kahan BD. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine. Transplantation. 1988 Feb; 45(2):333-7. PMID: 3278425.
      View in: PubMed
    106. Johnson PC, Lewis RM, Golden DL, Oefinger PE, Van Buren CT, Kerman RH, Kahan BD. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression. Transplantation. 1988 Jan; 45(1):116-21. PMID: 2827353.
      View in: PubMed
    107. Kerman RH, Van Buren CT, Lewis RM, Kahan BD. Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at Houston. Clin Transpl. 1988; 167-70. PMID: 3154469.
      View in: PubMed
    108. Kerman RH, Van Buren CT, Lewis RM, Kahan BD. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts. Transplantation. 1988 Jan; 45(1):37-40. PMID: 3276059.
      View in: PubMed
    109. Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone. Am J Kidney Dis. 1987 Jun; 9(6):476-84. PMID: 3296744.
      View in: PubMed
    110. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Kahan BD. Role of suppressor cells in cyclosporine-treated allograft recipients. Transplant Proc. 1987 Feb; 19(1 Pt 2):1580-3. PMID: 2950632.
      View in: PubMed
    111. Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD. Management of immunosuppressive problems in renal allograft recipients. Transplant Proc. 1987 Feb; 19(1 Pt 3):1951-4. PMID: 3547899.
      View in: PubMed
    112. Burstain TL, Frazier OH, Schnee MJ, Kerman RH, Lorber MI, Cooley DA, Radovancevic B, Colon R, McAllister H, Kahan BD, et al. Predictors of rejection in cyclosporine-treated cardiac allograft recipients. Transplant Proc. 1987 Feb; 19(1 Pt 3):2531-3. PMID: 2978895.
      View in: PubMed
    113. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Kahan BD. Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients. Transplantation. 1987 Feb; 43(2):205-10. PMID: 2949404.
      View in: PubMed
    114. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Dawson G, Falk L, Gutierrez R, Hollinger JB, Kahan BD. Investigation of HTLV-3 serology in a renal transplant population. Transplantation. 1987 Feb; 43(2):244-8. PMID: 3544383.
      View in: PubMed
    115. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Dawson G, Falk L, Gutierrez R, Hollinger JB, Kahan BD. Investigation of human T-lymphotropic virus III serology in a renal transplant population. Transplant Proc. 1987 Feb; 19(1 Pt 3):2172-5. PMID: 3547918.
      View in: PubMed
    116. Flechner SM, Kerman RH, Van Buren CT, Lorber MI, Barker CJ, Kahan BD. Does cyclosporine improve the results of HLA-identical renal transplantation? Transplant Proc. 1987 Feb; 19(1 Pt 2):1485-8. PMID: 3547866.
      View in: PubMed
    117. Kahan BD, Mickey R, Flechner SM, Lorber MI, Wideman CA, Kerman RH, Terasaki P, Van Buren CT. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients. Transplant Proc. 1987 Feb; 19(1 Pt 3):1835-8. PMID: 3547890.
      View in: PubMed
    118. Kahan BD, Mickey R, Flechner SM, Lorber MI, Wideman CA, Kerman RH, Terasaki P, Van Buren CT. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients. Transplantation. 1987 Jan; 43(1):65-70. PMID: 3541326.
      View in: PubMed
    119. Smith AY, Van Buren CT, Lewis RM, Kerman RH, Kahan BD. Factors determining renal transplant outcome at the University of Texas at Houston. Clin Transpl. 1987; 155-66. PMID: 3154393.
      View in: PubMed
    120. Kahan BD, Yoshimura N, Pellis NR, Burstain T, Van Buren CT, Leinikki P, Schreiber RD, Roesel TR, Kerman RH. Pharmacodynamics of cyclosporine. Transplant Proc. 1986 Dec; 18(6 Suppl 5):238-51. PMID: 2947366.
      View in: PubMed
    121. Wiseman C, Rao VS, Bakke A, Kerman R, Bouzaglou A, Presant C, McKenna RJ, Smith JD, Sakulsky SB. Increased T-helper lymphocytes following active specific intralymphatic immunotherapy of cancer. J Biol Response Mod. 1986 Oct; 5(5):490-7. PMID: 2945905.
      View in: PubMed
    122. Flechner SM, Van Buren CT, Kerman RH, Lorber MI, Barker CJ, Golden DL, Kahan BD. Long-term results of cyclosporine therapy in recipients of mismatched living related kidneys. Transplant Proc. 1986 Apr; 18(2 Suppl 1):44-51. PMID: 3515693.
      View in: PubMed
    123. Jarowenko M, Pifer L, Kerman R, Kahan BD. Serologic methods for the early diagnosis of Pneumocystis carinii infection in renal allograft recipients. Transplantation. 1986 Apr; 41(4):436-42. PMID: 3515643.
      View in: PubMed
    124. Appel SH, Stockton-Appel V, Stewart SS, Kerman RH. Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol. 1986 Mar; 43(3):234-8. PMID: 3484947.
      View in: PubMed
    125. Kahan BD, Kerman RH, Flechner SM, Lorber MI, Van Buren CT. Clinical results of ciclosporin-prednisone therapy in renal transplantation. Contrib Nephrol. 1986; 51:55-60. PMID: 3105957.
      View in: PubMed
    126. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Kahan BD. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches. Transplantation. 1985 Dec; 40(6):615-9. PMID: 3907031.
      View in: PubMed
    127. Flechner SM, Lorber MI, Kerman RH, Van Buren CT, Wideman C, Kahan BD. Does cyclosporine influence the results of cadaver retransplantation? Hum Immunol. 1985 Nov; 14(3):305-13. PMID: 3902748.
      View in: PubMed
    128. Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients. Transplant Proc. 1985 Aug; 17(4 Suppl 1):282-5. PMID: 3895668.
      View in: PubMed
    129. Flechner SM, Lorber M, Van Buren C, Kerman R, Kahan BD. The case against conversion to azathioprine in cyclosporine-treated renal recipients. Transplant Proc. 1985 Aug; 17(4 Suppl 1):276-81. PMID: 3895667.
      View in: PubMed
    130. Weiland AP, Daskal Y, Kerman R, Smalling RW, Williams JP, Walker WE. AIDS prodrome in an apparently normal man following coronary artery bypass: new significance of postoperative bleeding. Tex Heart Inst J. 1985 Jun; 12(2):195-7. PMID: 15227031; PMCID: PMC341839.
    131. Kahan BD, Kerman RH, Wideman CA, Flechner SM, Jarowenko M, Van Buren CT. Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston. Am J Kidney Dis. 1985 Jun; 5(6):288-95. PMID: 3925760.
      View in: PubMed
    132. Maddox AM, Kahan BD, Tucker S, Kerman R, Jordan RE. Remission in skin infiltrate of a patient with mycosis fungoides treated with cyclosporine. J Am Acad Dermatol. 1985 May; 12(5 Pt 2):952-6. PMID: 3158679.
      View in: PubMed
    133. Kahan BD, van Buren CT, Flechner SM, Jarowenko M, Yasumura T, Rogers AJ, Yoshimura N, LeGrue S, Drath D, Kerman RH. Clinical and experimental studies with cyclosporine in renal transplantation. Surgery. 1985 Feb; 97(2):125-40. PMID: 3881837.
      View in: PubMed
    134. Kerman R, Van Buren CT, Flechner S, Kahan BD. Correlation of visual 51Cr release and flow cytometry crossmatch results and graft survival. Transplant Proc. 1984 Dec; 16(6):1430-3. PMID: 6390843.
      View in: PubMed
    135. Rogers AJ, Kerman RH, Kahan BD. Immunopharmacodynamic profiles in renal transplant patients treated intravenously with cyclosporine. Transplant Proc. 1984 Dec; 16(6):1634-6. PMID: 6390877.
      View in: PubMed
    136. Rogers AJ, Yoshimura N, Kerman RH, Kahan BD. Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients. Transplantation. 1984 Dec; 38(6):657-64. PMID: 6239413.
      View in: PubMed
    137. Flechner SM, Kerman RH, Van Buren CT, Epps L, Kahan BD. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal. Transplantation. 1984 Dec; 38(6):685-91. PMID: 6239415.
      View in: PubMed
    138. Sterling RP, Bradley BB, Khalil KG, Kerman RH, Conklin RH. Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipients. Ann Thorac Surg. 1984 Nov; 38(5):494-9. PMID: 6388515.
      View in: PubMed
    139. Van Buren CT, Flechner SM, Kerman RH, Vaughn W, Kahan BD. Cyclosporine improves outcome in high-risk cadaveric renal allograft recipients. Transplant Proc. 1984 Oct; 16(5):1162-6. PMID: 6385365.
      View in: PubMed
    140. Kerman R, Manner C, Ford K, Hoots K. Comprehensive immune evaluation of seventy-eight hemophiliacs. Ann N Y Acad Sci. 1984; 437:540-3. PMID: 6242006.
      View in: PubMed
    141. Flechner SM, Kerman RH, Van Buren C, Kahan BD. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions. Transplantation. 1984 Jan; 37(1):73-6. PMID: 6229913.
      View in: PubMed
    142. Verani RR, Bergman D, Kerman RH. Glomerulopathy in acute and chronic rejection: relationship of ultrastructure to graft survival. Am J Nephrol. 1983 Sep-Oct; 3(5):253-63. PMID: 6356920.
      View in: PubMed
    143. Flechner SM, Payne WD, Van Buren C, Kerman R, Kahan BD. The effect of cyclosporine on early graft function in human renal transplantation. Transplantation. 1983 Sep; 36(3):268-72. PMID: 6351368.
      View in: PubMed
    144. Kerman RH, Van Buren CT, Payne W, Flechner S, Agostino G, Conley S, Brewer E, Kahan BD. The influence on pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survival. Transplantation. 1983 Jul; 36(1):50-4. PMID: 6223421.
      View in: PubMed
    145. Kerman RH. Influence of HLA, A, B, and DR antigen matching in transfused cadaver renal transplant patients. Cleve Clin Q. 1983; 50(2):216-7. PMID: 6357547.
      View in: PubMed
    146. Kerman RH, Conklin R, Cahall D, Van Buren CT, Kahan BD. CMV and renal allograft survival. Adv Exp Med Biol. 1983; 162:517-9. PMID: 6307017.
      View in: PubMed
    147. Agostino GJ, Kahan BD, Kerman RH. Suppression of mixed leukocyte culture using leukocytes from normal individuals, uremic patients, and allograft recipients. Transplantation. 1982 Dec; 34(6):367-71. PMID: 6218662.
      View in: PubMed
    148. Ono Y, Kerman RH, Kahan BD. Natural cell-mediated cytotoxicity and suppressor activity for natural cell-mediated cytotoxicity in long-term renal transplant patients. Transplantation. 1982 Aug; 34(2):103-7. PMID: 6215745.
      View in: PubMed
    149. Van Buren CT, Kerman R, Agostino G, Payne W, Flechner S, Kahan BD. The cellular target of cyclosporin A action in humans. Surgery. 1982 Aug; 92(2):167-74. PMID: 6213052.
      View in: PubMed
    150. Kahan BD, Van Buren CT, Lin SN, Ono Y, Agostino G, LeGrue SJ, Boileau M, Payne WD, Kerman RH. Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts. Transplantation. 1982 Jul; 34(1):36-45. PMID: 6214878.
      View in: PubMed
    151. Kerman RH, Van Buren CT, Payne W, Flechner S, Agostino G, Conley S, Brewer E, Kahan BD. Influence of blood transfusions on immune responsiveness. Transplant Proc. 1982 Jun; 14(2):335-7. PMID: 6214061.
      View in: PubMed
    152. Kerman RH. Effect of blood transfusion on renal allograft survival: immunologic considerations. Am J Kidney Dis. 1981 Sep; 1(2):125-7. PMID: 7036716.
      View in: PubMed
    153. Kerman RH, Floyd M, Van Buren CT, Kahan BD. Prediction of cadaveric allograft survival based on pretransplant nonspecific immunocompetence. Transplant Proc. 1981 Sep; 13(3):1533-5. PMID: 7029808.
      View in: PubMed
    154. Kerman RH, Floyd M, Van Buren C, Kahan BD. Serial measurement of nonspecific immune parameters in chronically hemodialyzed renal failure patients. J Clin Immunol. 1981 Jul; 1(3):163-8. PMID: 6977554.
      View in: PubMed
    155. Kerman RH, Floyd M, Van Buren C, McConnell BJ, McConnell R, Kahan BD. Correlation of nonspecific immune monitoring with rejection or impaired function of renal allografts. Transplantation. 1981 Jul; 32(1):16-23. PMID: 7022794.
      View in: PubMed
    156. Kerman RH, Floyd M, Van Buren CT, Kahan BD. Prolonged allograft survival of strong pretransplant immune responders treated with ATG. Transplant Proc. 1981 Mar; 13(1 Pt 1):332-5. PMID: 6455793.
      View in: PubMed
    157. Kerman RH, Kahan BD. Immunological evaluation of transplant rejection: pre and postoperative indices detecting immune responsiveness. Ann Clin Res. 1981; 13(4-5):244-63. PMID: 6461287.
      View in: PubMed
    158. Kerman RH, Floyd M, Van Buren CT, Kahan BD. Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapy. Transplantation. 1980 Dec; 30(6):450-4. PMID: 7008294.
      View in: PubMed
    159. Kerman RH, Floyd M, Conner W, McConnell R, McConnell BJ, Van Buren CT, Kahan BD. Combined immunologic and radionuclide techniques to monitor renal allograft rejection. Transplant Proc. 1979 Jun; 11(2):1229-31. PMID: 382493.
      View in: PubMed
    160. Geis WP, Giacchino JL, Buckingham JM, Bansal VK, Iwatsuki S, Kerman RH, Ing TS, Hano JE. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG? Transplant Proc. 1979 Jun; 11(2):1433-4. PMID: 382533.
      View in: PubMed
    161. Kerman RH, Ing TS, Hano JE, Geis WP. Predictive value of active T-RFC in renal allograft survival. Transplant Proc. 1978 Sep; 10(3):637-8. PMID: 362650.
      View in: PubMed
    162. Kerman RH, Geis WP. T-RFC monitoring of CMI events in renal allograft recipients. Transplant Proc. 1978 Sep; 10(3):633-5. PMID: 362649.
      View in: PubMed
    163. Dodson MG, Klegerman ME, Menon M, Kerman RH, Lange CF, O'Leary JA. Establishment and characterization of a squamous cell carcinoma of the vulva in tissue culture and immunologic evaluation of the host. Am J Obstet Gynecol. 1978 Jul 15; 131(6):606-19. PMID: 686047.
      View in: PubMed
    164. Dodson MG, Klegerman ME, Kerman RH, Lange CF, Tessler HH, O'Leary JA. Behcet syndrome: with immunologic evaluation. Obstet Gynecol. 1978 May; 51(5):621-5. PMID: 652213.
      View in: PubMed
    165. Geis WP, Iwatsuki S, Molnar Z, Giacchino JL, Kerman RH, Ing TS, Hano JE. Pseudolymphoma in renal allograft recipients. Arch Surg. 1978 Apr; 113(4):461-6. PMID: 205191.
      View in: PubMed
    166. Marshack M, Toto P, Kerman R. Immunotherapy of chemically-induced tumors in the hamster cheek pouch with dinitrochlorobenzene. J Dent Res. 1978 Apr; 57(4):625-30. PMID: 101565.
      View in: PubMed
    167. Kahan BD, Kerman RH, McConnell R. Combination of immunologic and radionuclide techniques to diagnose allograft rejection. Surg Forum. 1978; 29:364-6. PMID: 401412.
      View in: PubMed
    168. Kerman RH, Ing TS, Hano JE, Geis WP. Prognostic significance of the active thymus derived rosette forming cells in renal allograft survival: a preliminary report. Surgery. 1977 Nov; 82(5):607-12. PMID: 335551.
      View in: PubMed
    169. Stefani SS, Kerman RH. Lymphocyte response to phytohaemagglutinin before and after radiation therapy in patients with carcinomas of the head and neck. J Laryngol Otol. 1977 Jul; 91(7):605-9. PMID: 302294.
      View in: PubMed
    170. Dodson MG, Kerman RH, Lange CF, Stefani SS, O'Leary JA. T and B cells in pregnancy. Obstet Gynecol. 1977 Mar; 49(3):299-302. PMID: 300152.
      View in: PubMed
    171. Marshack M, Toto P, Kerman R. Delayed hypersensitivity in the hamster cheek pouch. J Immunol Methods. 1977; 15(4):325-30. PMID: 326968.
      View in: PubMed
    172. Kerman RH, Stefani SS. Phytohemagglutinin stimulation of lymphocytes in lung cancer patients. Oncology. 1977; 34(1):10-2. PMID: 865758.
      View in: PubMed
    173. Kerman RH, Smith R, Stefani SS, Ezdinili EZ. Active T-rosette-forming cells in the peripheral blood of cancer patients. Cancer Res. 1976 Sep; 36(9 pt.1):3274-8. PMID: 1086131.
      View in: PubMed
    174. Stefani S, Kerman R, Abbate J. Immune evaluation of lung cancer patients undergoing radiation therapy. Cancer. 1976 Jun; 37(6):2792-6. PMID: 181124.
      View in: PubMed
    175. Kerman RH, Geis WP. Total and active T cell dynamics in renal allograft recipients. Surgery. 1976 Apr; 79(4):398-407. PMID: 769220.
      View in: PubMed
    176. Stefano S, Kerman R, Abbate J. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy. AJR Am J Roentgenol. 1976 Apr; 126(4):880-6. PMID: 179361.
      View in: PubMed
    177. Kerman R, Smith R, Ezdinli E, Stefani S. Unification and technical aspects of total t, active t and b lymphocyte rosette assays. Immunol Commun. 1976; 5(7-8):685-94. PMID: 791851.
      View in: PubMed
    178. Smith R, Kerman R, Ezdinli E, Stefani S. A modified assay for the detection of human adult active rosette forming lymphocytes. J Immunol Methods. 1975; 8(1-2):175-84. PMID: 1080175.
      View in: PubMed
    179. Kerman RH, Harris TN. Resistance to denaturation by periodate of a dialyzable form of BALB-c histocompatibility antigen. Proc Soc Exp Biol Med. 1972 Oct; 141(1):179-83. PMID: 4344742.
      View in: PubMed
    180. Kerman RH, Harris TN, Harris S. Preparation of dialyzable histocompatibility antigen from BALB-c mice (cell-membrane fragments-proteolytic digestion-detergent solubilization). Proc Natl Acad Sci U S A. 1972 Jan; 69(1):223-7. PMID: 4500549; PMCID: PMC427580.
    181. Kerman R, Segre D. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: cellular response in immunity and immunologic paralysis. J Immunol. 1970 May; 104(5):1262-6. PMID: 4392712.
      View in: PubMed
    182. Kerman R, Segre D, Myers WL. The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3. J Immunol. 1970 Mar; 104(3):656-64. PMID: 4190969.
      View in: PubMed
    183. Kerman R, Segre D, Myers WL. Altered response to pneumococcal polysaccharide in offspring of immunologically paralyzed mice. Science. 1967 Jun 16; 156(3781):1514-6. PMID: 4388423.
      View in: PubMed
    KERMAN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _